Conduit Pharmaceuticals to Present at the Oppenheimer 34th A

SAN DIEGO and LONDON, Jan. 31, 2024 -- Conduit Pharmaceuticals Inc. , a multi-asset, clinical-stage life science company delivering an efficient model for compound development, today announced CEO...

Related Keywords

London , City Of , United Kingdom , Sean Leous , Freda Lewis Hall , David Tapolczay , Healthcare Life Sciences Conference , Globenewswire Inc , Company Events , Drug Administration , Conduit Pharmaceuticals , Exchange Commission , Conduit Pharmaceuticals Inc , Nasdaq , Life Sciences Conference , Markets ,